| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... nature 500 (7463), 415-421, 2013 | 10343 | 2013 |
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ... Journal of the National Cancer Institute 98 (4), 262-272, 2006 | 2357 | 2006 |
| Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016 | 2314 | 2016 |
| The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 1946 | 2012 |
| Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial S Loi, S Michiels, R Salgado, N Sirtaine, V Jose, D Fumagalli, ... Annals of oncology 25 (8), 1544-1550, 2014 | 1390 | 2014 |
| Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007 | 1097 | 2007 |
| CD4+ follicular helper T cell infiltration predicts breast cancer survival C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ... The Journal of clinical investigation 123 (7), 2873-2892, 2013 | 1095 | 2013 |
| Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ... Breast Cancer Research 10, 1-11, 2008 | 1056 | 2008 |
| Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ... Clinical cancer research 14 (16), 5158-5165, 2008 | 958 | 2008 |
| Definition of clinically distinct molecular subtypes in estrogen receptor–positive breast carcinomas through genomic grade S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ... Journal of clinical oncology 25 (10), 1239-1246, 2007 | 947 | 2007 |
| Subclonal diversification of primary breast cancer revealed by multiregion sequencing LR Yates, M Gerstung, S Knappskog, C Desmedt, G Gundem, P Van Loo, ... Nature medicine 21 (7), 751-759, 2015 | 862 | 2015 |
| Genomic evolution of breast cancer metastasis and relapse LR Yates, S Knappskog, D Wedge, JHR Farmery, S Gonzalez, ... Cancer cell 32 (2), 169-184. e7, 2017 | 688 | 2017 |
| A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer A Bassez, H Vos, L Van Dyck, G Floris, I Arijs, C Desmedt, B Boeckx, ... Nature medicine 27 (5), 820-832, 2021 | 490 | 2021 |
| Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ... Science 345 (6196), 1251343, 2014 | 457 | 2014 |
| Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ... BMC genomics 9, 1-12, 2008 | 428 | 2008 |
| Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer Y Li, L Zou, Q Li, B Haibe-Kains, R Tian, Y Li, C Desmedt, C Sotiriou, ... Nature medicine 16 (2), 214-218, 2010 | 402 | 2010 |
| A three-gene model to robustly identify breast cancer molecular subtypes B Haibe-Kains, C Desmedt, S Loi, AC Culhane, G Bontempi, ... Journal of the National Cancer Institute 104 (4), 311-325, 2012 | 378 | 2012 |
| Genomic characterization of primary invasive lobular breast cancer C Desmedt, G Zoppoli, G Gundem, G Pruneri, D Larsimont, M Fornili, ... Journal of clinical oncology 34 (16), 1872-1881, 2016 | 324 | 2016 |
| Genomic index of sensitivity to endocrine therapy for breast cancer WF Symmans, C Hatzis, C Sotiriou, F Andre, F Peintinger, P Regitnig, ... Journal of clinical oncology 28 (27), 4111-4119, 2010 | 289 | 2010 |
| Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer F Rothe, M Ignatiadis, C Chaboteaux, B Haibe-Kains, N Kheddoumi, ... PloS one 6 (6), e20980, 2011 | 278 | 2011 |
Christos SotiriouUniversité Libre de BruxellesDirección de correo verificada de bordet.be